12:00 AM
Sep 26, 2016
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ameluz aminolevulinic acid regulatory update

The European Commission approved a label expansion for Biofrontera’s Ameluz aminolevulinic acid to include treatment of actinic keratosis of field cancerization. Field cancerization...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >